Umbilical cord blood natural killer cells for adoptive immunotherapy: identifying optimal starting material and processing parameters
IntroductionUmbilical cord blood (UCB) is an attractive source of natural killer (NK) cells for the development of allogeneic ‘off-the-shelf’ cancer immunotherapies. This is due to the relatively high proportion of highly proliferative NK cells compare…